{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:55:17Z","timestamp":1768208117087,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ajog.2005.08.059","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:24:53Z","timestamp":1139405093000},"page":"457-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impaired factor XIIa\u2013dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications"],"prefix":"10.1016","volume":"194","author":[{"given":"Francisco","family":"Carmona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"T\u00e0ssies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Balasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2005.08.059_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","article-title":"The antiphospholipid syndrome: ten years on","volume":"342","author":"Hughes","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2005.08.059_bib2","series-title":"The antiphospholipid syndrome II: autoimmune thrombosis","first-page":"375","article-title":"Management of reproductive failure in the antiphospholipid syndrome","author":"Balasch","year":"2002"},{"key":"10.1016\/j.ajog.2005.08.059_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0897.2001.d01-13.x","article-title":"Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis","volume":"46","author":"Carmona","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2005.08.059_bib4","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience","volume":"80","author":"Branch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.08.059_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/096120339400300414","article-title":"Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome","volume":"3","author":"Branch","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2005.08.059_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1471-0528.1999.tb08208.x","article-title":"Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin","volume":"106","author":"Backos","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2005.08.059_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0897.1999.tb00087.x","article-title":"Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome","volume":"41","author":"Kutteh","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2005.08.059_bib8","first-page":"407","article-title":"Recent insights into antiphospholipid antibody-mediated thrombosis","volume":"12","author":"Field","year":"1999","journal-title":"Baillieres Clin Hematol"},{"key":"10.1016\/j.ajog.2005.08.059_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1568-9972(02)00144-1","article-title":"Antiphospholipid syndrome: pathogenic mechanisms","volume":"2","author":"Espinosa","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajog.2005.08.059_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0378(00)00061-9","article-title":"Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy","volume":"47","author":"Sugi","year":"2000","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2005.08.059_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0165-0378(01)00088-2","article-title":"Autoantibodies to contact proteins in patients with recurrent pregnancy losses","volume":"53","author":"Sugi","year":"2002","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2005.08.059_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0897.2002.01103.x","article-title":"Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review","volume":"47","author":"Sugi","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2005.08.059_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1191\/0961203302lu132oa","article-title":"Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies","volume":"11","author":"Donohoe","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2005.08.059_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9150(02)00196-X","article-title":"Association of the factor XII 46C > T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study","volume":"165","author":"Zito","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajog.2005.08.059_bib15","series-title":"Danfort's obstetrics and gynecology","first-page":"29","article-title":"Embryo, fetus, and placenta: normal and abnormal","author":"Craven","year":"1999"},{"key":"10.1016\/j.ajog.2005.08.059_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2005.08.059_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0020-7292(02)00328-4","article-title":"ACOG practice bulletin. Perinatal care at the threshold of viability. No. 38, September 2002","volume":"79","author":"American College of Obstetrics and Gynecology","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2005.08.059_bib18","series-title":"Danforth's obstetrics and gynecology","first-page":"257","article-title":"Hypertensive disorders of pregnancy","author":"Moldenhauer","year":"2003"},{"key":"10.1016\/j.ajog.2005.08.059_bib19","series-title":"Medicine of the fetus and mother","first-page":"267","article-title":"Biology of normal and deviant fetal growth","author":"Nimrod","year":"1999"},{"key":"10.1016\/j.ajog.2005.08.059_bib20","series-title":"Medicine of the fetus and mother","first-page":"997","article-title":"Hypertensive diseases in pregnancy","author":"Witlin","year":"1999"},{"key":"10.1016\/j.ajog.2005.08.059_bib21","series-title":"Medicine of the fetus and mother","first-page":"1529","article-title":"Preterm labor","author":"Amon","year":"1999"},{"key":"10.1016\/j.ajog.2005.08.059_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.siny.2004.03.007","article-title":"Prenatal diagnosis of fetal growth restriction","volume":"9","author":"Bamberg","year":"2004","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2005.08.059_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria the diagnosis of lupus anticoagulant: an update. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2005.08.059_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0037-1614949","article-title":"Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries","volume":"79","author":"Kienast","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2005.08.059_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ajog.2005.08.059_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Sem Thromb Hemost"},{"key":"10.1016\/j.ajog.2005.08.059_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.1993.tb15264.x","article-title":"Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension of pre-eclampsia","volume":"100","author":"Cadroy","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2005.08.059_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia","volume":"101","author":"Halligan","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2005.08.059_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2141.1998.00514.x","article-title":"Longitudinal study on activated factors XII and VII levels during normal pregnancy","volume":"100","author":"de Moerloose","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2005.08.059_bib30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0038-1651601","article-title":"Influence of anticoagulants upon prothrombin fragment 1+2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis","volume":"69","author":"Elias","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2005.08.059_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1046\/j.1432-1327.1999.00593.x","article-title":"Fibrinolytic properties of activated FXII","volume":"263","author":"Braat","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ajog.2005.08.059_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1191\/0961203303lu397oa","article-title":"Activation of complement mediates antiphospholipid antibody-induced pregnancy loss","volume":"12","author":"Salmon","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2005.08.059_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajog.2005.08.059_bib34","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2005.08.059_bib35","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805013840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805013840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:16:16Z","timestamp":1757585776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937805013840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0002937805013840"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2005.08.059","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired factor XIIa\u2013dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2005.08.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}